Capivasertib is an AKT inhibitor for HR /HER2breast cancer, targeting PIK3CA/AKT1/PTEN alterations. It’s all about shutting down that AKT signaling. The dosage options are pretty simple; you got 200 mg and 400 mg pills.
The doc usually recommends going with the 400 mg stuff and taking it twice a day for four days straight, then taking a break for three days. The product comes in these bottles that hold 64 tablets each.
Reviews
There are no reviews yet.